Biological interventions for spinal cord injury

Current Opinion in Neurology

Volumn 11, Issue 6, 1998, Pages 647-654

  Giménez Y Ribotta, Minerva ^a,b   Privat, Alain ^a  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR;

CELL TRANSPLANTATION; GENE THERAPY; HUMAN; MONOAMINERGIC SYSTEM; NERVE FIBER; NERVE FIBER REGENERATION; NERVE STIMULATION; NEUROPROTECTION; REVIEW; SPINAL CORD INJURY; TIME;

ANIMALS; GENE THERAPY; HUMANS; NERVE GROWTH FACTORS; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; SPINAL CORD; SPINAL CORD INJURIES; TISSUE THERAPY; TREATMENT OUTCOME;

EID: 0031743987     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199812000-00007     Document Type: Review

References (80)

1. Morin-Richaud C, Feldblum S, Privat A. Astrocytes and oligodendrocytes reactions after a total section of the rat spinal cord. Brain Res 1998; 783:85-101.
2. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20:570-577. This review highlights the permissive and obstructive characteristics of reactive astrocytes, and indicates several possibilities of modifying or using them to promote axonal regrowth.
3. DiProspero NA, Meiners S, Geller HM. Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol 1997; 148:628-639.
4. Fernaud-Espinosa I, Nieto-Sampedro M, Bovolenta P. Differential activation of microglia and astrocytes in anisomorphic and isomorphic gliotic tissue. Glia 1993; 8:277-291.
5. Alonso G, Prieto M, Legrand A, Chauvet N: PSA-NCAM and B-50/GAP-43 are coexpressed by specific neuronal systems of the adult rat mediobasal hypothalamus that exhibit remarkable capacities for morphological plasticity. J Comp Neurol 1997; 384:181-199.
6. Brook GA, Schmitt AB, Nacimiento W, Weis J, Schroder JM, Noth J. Distribution of B-50 (GAP-43) mRNA and protein in the normal adult human spinal cord. Acta Neuropathol 1998; 95:378-386.
7. Thallmair M, Metz GAS, Graggen WJZ, Raineteau O, Kartje GL, Schwab ME. Neurite growth inhibitors restrict plasticity and functional recovery following corsticospinal tract lesions. Nature Neurosci 1998; 1:124-131.
8. Privat A, Chauvet N, Giménez y Ribotta M. Neuronal regeneration and the glial barrier. Rev Neurol 1997; 153:515-520.
9. Steward O, Kelley MS, Schauwecker PE. Signals that regulate astroglial gene expression; Induction of GFAP mRNA following seizures or injury is blocked by protein synthesis inhibitors. Exp Neurol 1997; 148:100-109.
10. Zompa EA, Cain LD, Everhart AW, Moyer MP, Hulsebosch CE. Transplant therapy: recovery of function after spinal cord injury. J Neurotrauma 1997, 14:479-506.
11. Chau C, Barbeau H, Rossignol S. Early locomotor training with clonidine in spinal cats. J Neurophysiol 1998; 79:392-409. This report illustrates the combined use of a pharmacological treatment (clonidine) and of sensory stimulation to optimize the restoration of locomotion in paraplegic cats. Such a study contributes to elaborate a strategy for rehabilitation of paraplegic patients.
12. Feraboli-Lohnherr D, Orsal D, Yakovleff A, Giménez y Ribotta M, Privat A. Recovery of locomotor activity in the adult chronic spinal rat after sublesional transplantation of embryonic nervous cells: specific role of serotonergic neurons. Exp Brain Res 1997; 113:443-454. This study demonstrates for the first time that transplants of serotonergic neurones are able to activate the lumbar central pattern generator for locomotion in paraplegic rats.
13. Giménez y Ribotta M, Orsal O, Feraboli-Lohnherr D, Privat A. Neuronal mechanisms for generating locomotor activity: recovery of locomotion following transplantation of monoaminergic neurons in the spinal cord of parplegic rats. Ann NY Acad Sci 1998 (in press).
14. McIntosh TK. Neurochemical sequelae of traumatic brain injury: therapeutic implications. Cerebrovasc Brain Metab Rev 1994; 6:109-162.
15. Olney JW. Neurotoxicity of excitatory amino acids. In: Kainic acid as a tool in neurobiology. McGees EG (editor): New York: Raven Press; 1978. pp. 95-121.
16. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19:105-111.
17. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7:357-368.
18. Rondouin G, Drian MJ, Chicheportiche R, Kamenka JM, Privat A. Non-competitive antagonists of N-methyl-D-aspartate receptors protect cortical and hippocampal cell cultures against glutamate neurotoxicity. Neurosci Lett 1988; 91:199-203.
19. Levallois C, Calvet MC, Petite D, Kamenka JM. Neuroprotective effect of N-methyl-D-aspartate non-competitive antgonists (arylcyclohexylamine derivatives) on human cultured spinal cord cells Int J Dev Neurosci 1994; 12:547-555.
20. Farooque M, Hillered L, Holtz A, Olsson Y. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis. J Neurotrauma 1996; 13:537-548.
21. Watanabe M, Fujimura Y, Nakamura M, Yato Y, Ohta K, Okai H, Ogawa Y. Changes of amino acid levels and asparate distribution in the cervical spinal cord after traumatic spinal cord injury. J Neurotrauma 1998; 15:285-293.
22. + influx underlies potent induction of injury. J Neurosci 1996, 16:5457-5465.
23. Mukhin AG, Ivanova SA, Knoblach SM, Faden AI. New in vitro model of traumatic neuronal injury evaluation of secondary injury and glutamate receptor-mediated neurotoxicity. J Neurotrauma 1997; 14:651-663.
24. Hughes S, Lowrie MB, Smith ME. N-methyl-D-aspartate receptors in motoneurones after unilateral axotomy in the neonatal rat. Dev Brain Res 1997; 102:13-20.
25. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995; 65:643-651.
26. Wrathall JR, Teng YD, Marriott R. Delayed antgonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol 1997; 145:565-573.
27. Faden AI, Ellison JA, Noble LJ. Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury. Eur J Pharmacol 1990; 175:165-174.
28. Pencalet P, Ohanna F, Poulat P, Kamenka JM, Privat A. Thienylphencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury. J Neurosurg 1993; 78:603-609.
29. Sundström E, Whittemore S, Mo LL, Seiger A. Analysis of NMDA receptors in the human spinal cord. Exp Neurol 1997; 148:407-413.
30. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17:9157-9164. This elegant study identifies the implication of inducible nitric oxide synthase in traumatic brain injury. The use of knockout mutant mice in this regard is of particular interest for the future development of this line of research.
31. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322:1405-1411.
32. Kanellopoulos GK, Kato H, Wu Y, Dougenis D, Mackey M, Hsu CY, Kouchoukos NT. Neuronal cell death in the ischemic spinal cord: the effect of methylprednisolone. Ann Thorac Surg 1997; 64:1279-1285.
33. Regan RF, Panter SS. Traumatic neuronal injury in cortical cell culture is attenuated by 21-aminosteroids. Brain Res 1995; 682:144-150.
34. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998; 151:77-88.
35. Taoka Y, Okajima K, Uchiba M, Murakami K, Harada N, Johno M, Naruo M. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 1998; 18: 1393-1398.
36. Klusman I, Schwab ME. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 1997; 762:173-184.
37. Teng YD, Mocchetti I, Wrathall JR. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur J Neurosci 1998; 10:798-802.
38. Giménez y Ribotta M, Revah F, Pradier L, Loquet I, Mallet J, Privat A. Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 1997; 48:281-285.
39. Vanek P, Thallmair M, Schwab ME, Kapfhammer JP. Increased lesion-induced sprouting of corticospinal fibres in the myelin-free rat spinal cord. Eur J Neurosci 1998; 10:45-56.
40. Giménez y Ribotta M, Rajaofetra N, Morin-Richaud C, Alonso G, Bochelen D, et al. Oxysterol (7β-hydroxycholesteryl-3-oleate) promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res 1995; 41:79-95.
41. Keirstead HS, Hughes HC, Blakemore WF. A quantifiable model of axonal regeneration in the demyelinated adult rat spinal cord. Exp Neurol 1998; 151:303-313.
42. Bregman BS, Kunkelbagden E, Schnell L, Dai HN, Gao D, Schwab ME. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995; 378:498-501.
43. Tello F. La influencia del neurotropismo en la regeneración de los centros nerviosos. Trab Lab Invest Biol 1911; 9:123-159.
44. David S, Aguayo AJ. Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rate. Science 1981; 214:931-933.
45. Cheng H, Almström S, Giménez Llort L, Chang R, Ove Ogren S, Hoffer B, Olson L. Gait analysis of adult paraplegic rats after spinal cord repair. Exp Neurol 1997; 148:544-557.
46. Liu S, Peulve P, Jin O, Boisset N, Tiollier J, Said G, Tadie M. Axonal regrowth through collagen tubes bridging the spinal cord to nerve roots. J Neurosci Res 1997; 49:425-432.
47. Franzen R, Schoenen J, Leprince P, Joosten E, Moonen G, Martin D. Effects of macrophage transplantation in the injured adult rat spinal cord: a combined immunocytochemical and biochemical study. J Neurosci Res 1998; 51:316-327.
48. Prewitt CM, Niesman IR, Kane CJ, Houlé JD. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 1997; 148:433-443.
49. Guest JD, Rao A, Olson L, Bunge MB, Bunge RP. The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol 1997; 148:502-522.
50. Ramón-Cueto A, Plant GW, Avila J, Bunge MB. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 1998; 18:3803-3815. This paper illustrates the ability of olfactory ensheathing glia to promote axonal regeneration in the spinal cord. This particular type of glia is present only in the olfactory bulb, and accounts for the permissiveness of adult olfactory bulb to axonal growth. After transplantation in a transected spinal cord, bridged with Schwann cells, ensheathing glila associate with regenerating axons and migrate with them over at least 1.5 cm in white as well as grey matter.
51. Ramón-Cueto A, Avila J. Olfactory ensheathing glia: properties and functions. Brain Res Bull 1998; 46:175-187.
52. Li Y, Field PM, Raismn G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 1997; 277:2000-2002. This paper illustrates the ability of grafted olfactory ensheathing glia to promote the regeneration of the corticospinal tract, and to restore a specific function (forepaw reaching) associated with the corticospinal projection. Some of the ensheathing glia cells are claimed to behave like Schwann cells, by myelinating regenerating axons.
53. Diener PS, Bregman BS. Fetal spinal cord transplants support growth of supraspinal and segmental projections after cervical spinal cord hemisection in the neonatal rat. J Neurosci 1998, 18:779-793.
54. Bregman BS, McAtee M, Dai HN, Kuhn PL. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol 1997; 148:475-494.
55. Bregman BS, Broude E, McAtee M, Kelley MS. Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp Neurol 1998; 149:13-27.
56. Wictorin K, Bjorklund A. Axon outgrowth from grafts of human embryonic spinal cord in the lesioned adult rat spinal cord. Neuro Report 1992; 3:1045-1048.
57. Akesson E, Kjaeldgaard A, Seiger A. Human embryonic spinal cord grafts in adult rat spinal cord cavities: survival, growth, and interactions with the host. Exp Neurol 1998; 149:262-276.
58. Hollmaat AJGD, Oestreicher AB, Gispen WH, Verhaagen J. Manipulation of gene expression in the mammalian nervous system: application in the study of neurite outgrowth and neuroregeneration-related proteins. Brain Res Rev 1998; 26:43-71.
59. Cot C, Privat A, Levallois C. Adenoviral-mediated transfection of the lac-Z gene into rat dissociated embryonic central nervous system cells before and after seeding. Int J Dev Neurosci 1998; 16:9-17.
60. Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by graft of genetically modified NGF-secreting cells. Ep Neurol 1997; 148:444-452.
61. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997; 17:5560-5572. This paper illustrates the use of modified non-neural cells to deliver a neurotrophin (neurotrophin-3), which stimulates the regeneration of injured corticospinal axons and permits partial recovery of function.
62. Tuszynski MH, Weidner N, McCormack M, Miller I, Powell H, Conner J: Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination. Cell Transplant 1998, 7:187-196.
63. Eidelberg E, Nguyen LH, Polich R, Walden JG. Transsynaptic degeneration of motoneurones caudal to spinal cord lesions, Brain Res Bull 1989; 22:39-45.
64. Bjugn R, Nyengaard JR, Rosland JH. Spinal cord transection-no loss of distal ventral horn neurons-modem stereological techniques reveal no transneuronal changes in the ventral horns of the mouse lumbar spinal cord after thoracic cord transection. Exp Neurol 1997; 148:179-186.
65. Finiels F, Giménez y Ribotta M, Barkats M, Samolyk ML, Robert JJ, Privat A, et al. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuro Report 1995; 7:373-378.
66. Baumgartner BJ, Shine HD. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997; 17:6504-6511.
67. Li Y, Raisman G. Integration of transplanted cultured Schwann cells into the long myelinated fiber tracts of the adult spinal cord. Exp Neurol 1997; 145:397-411.
68. Chauvet N, Prieto M, Alonso G. Tanycytes present in the adult rat mediobasal hypothalamus support the regeneration of monoaminergic axons. Exp Neurol 1998; 151:1-13. This study illustrates the capacity of a particular category of glial cells, the tanycytes of basal hypothalamus, to support the regeneration of monoaminergic axons. In some respects tanycytes behave like olfactory bulb ensheathing cells, with which they share several cellular and molecular characteristics.
69. Davies SJA, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390:680-683.
70. Rossignol S, Dubuc R. Spinal pattern generation. Curr Opin Neurobiol 1994; 4:894-902.
71. Barbeau H, Rossignol S. Enhancement of locomotor recovery following spinal cord injury. Curr Opin Neurol 1994; 7:517-524.
72. Wickelgren I. Teaching the spinal cord to walk. Science 1998; 279:319-321.
73. Muir GD, Steeves JD. Sensorimotor stimulation to improve locomotor recovery after spinal cord injury. Trends Neurosci 1997; 20:72-77.
74. Felici F, Bernardi M, Radio A, Marchettoni P, Castellano V, Macaluso A. Rehabilitation of walking for paraplegic patients by means of a treadmill. Spinal Cord 1997; 35:383-385.
75. Rossignol S. Neural control of stereotypic limb movements. In: Handbook of physiology. Section 12. Exercise: regulation and integration of multiple systems. Rowell LB, Sheperd JT (editors). Bethesda: American Physiological Society; 1966. pp. 173-216.
76. Lundberg A. Integration in the reflex pathway. In: Muscular afferents and motor control. Granit R (editor). Stockholm: Almquist and Wiksell; 1966. pp. 275-305.
77. Gerin C, Privat A. Direct evidence for the link between monoaminergic descending pathways and motor activity: II. A study with microdialysis probes implanted in the ventral horn of the spinal cord. Brain Res 1998; 794:169-173.
78. Privat A, Mansour H, Geffard M. Transplanatation of foetal serotonin neurons into the transected spinal cord of adult rats: morphological development and functional influence. Prog Brain Res 1988; 78:155-166.
79. Giménez y Ribotta M, Roudet C, Privat A. Anatomical and functional characteristics of transplanted monoaminergic neurons in paraplegic rats. In: Advances in experimental medicine and biology: brain plasticity. Filogamo G, Vernadakis A, Cremo F, Privat A, Timiras PS (editors). New York: Plenum Press; 1997; 429:121-136.
80. Yakovleff A, Cabelguen JM, Orsal D, Giménez y Ribotta M, Rajaofetra N, Drian MJ, et al. Fictive motor activities in adult chronic spinal rats transplanted with embryonic brainstem neurons. Exp Brain Res 1995; 106:69-78.